Modified Gifu Anaerobic Medium (mGAM)
- Product Code: GMNB-MGAM01
- Availability: In Stock
Overview
The 'Modified' variant (mGAM, Nissui 05426) reduces glucose from 3 g/L in the original GAM to 0.5 g/L. This change minimises pH drift during long incubations, a critical requirement for slow-growing strict anaerobes. The dual-reductant system — L-cysteine 0.5 g/L plus sodium thioglycolate 0.3 g/L — gives a lower equilibrium Eh than single-reductant media and is one of the defining technical features of the medium. Hemin (5 mg/L) supports haem-auxotrophic Bacteroides; menadione is not in the standard formulation but can be added on request. The medium positions GMExpression for the Japanese-language anaerobic-microbiology market — including Filgen, NACALAI TESQUE, Shigematsu, AS ONE distributor channels — and for Korean and Taiwanese pharma R&D laboratories that follow Japanese microbiology conventions.
We also have
YCFA Modified Medium · YCFA Full Recipe · YCFA Base · Modified Chopped Meat Broth (ATCC 1490) · Chopped Meat with Carbohydrates · Beef Granules
Package Contents
Each GMExpression Modified GAM kit contains:
- Mixture A — pre-weighed mGAM base (peptone, soya peptone, proteose peptone No. 3, digest serum, yeast extract, beef extract, liver extract, glucose 0.5 g/L, NaCl, soluble starch, L-cysteine·HCl, sodium thioglycolate, L-tryptophan, hemin, K2HPO4) for 5 L final volume.
- Optional Stock M — Menadione (Vitamin K3) stock, 1 mg/mL in ethanol, for users adding menadione (not in standard mGAM).
- Optional Stock H — Hemin top-up stock for batches requiring additional hemin.
- 5 × airtight PP storage bags + 5 × heat-resistant rubber bands for PRAS-format dispensing.
- Instruction manual (A5 booklet, v1.0).
Customisation options on request: agar variant at 15 g/L for plates (Modified GAM Agar, Nissui 05425); semi-solid variant at 5 g/L agar for cysts/spore preservation; menadione-supplemented variant for routine clinical Bacteroides isolation; configure for Hungate-tube AAE workflows.
Composition — per 1 L equivalent unless stated otherwise
Modified GAM Broth (Nissui 05426; Mitsuoka 1965 + modification; per 1 L)
| Component | Concentration | Function |
|---|---|---|
| Peptone (mixed pancreatic digest) | 5.0 g | Peptide nitrogen source |
| Soya peptone | 3.0 g | Plant-derived peptide source |
| Proteose Peptone No. 3 | 10.0 g | High-quality casein digest, growth factors |
| Digested serum solids | 13.5 g | Complex protein source, growth factors |
| Yeast extract | 2.5 g | B-vitamins, NAD precursors |
| Beef extract | 2.2 g | Amino acid mixture, peptides |
| Liver extract | 1.2 g | Iron, B12, folate, haem precursors |
| D-Glucose | 0.5 g | Reduced from 3 g/L original GAM — minimises pH drift |
| Sodium chloride (NaCl) | 3.0 g | Osmotic balance |
| Soluble starch | 5.0 g | Trace-toxin absorption; supports starch-fermenting organisms |
| L-Cysteine·HCl·H2O | 0.5 g | Reductant component 1 |
| Sodium thioglycolate | 0.3 g | Reductant component 2 — dual-reductant system |
| L-Tryptophan | 0.2 g | Indole testing substrate |
| Hemin | 5.0 mg | Haem source for Bacteroides |
| Dipotassium phosphate (K2HPO4) | 2.5 g | Phosphate buffer |
Pre-autoclaving pH: 7.3 ± 0.1 at 25 °C. Adjust with 1 M NaOH or 1 M HCl as required.
Modified GAM Agar variant
| Component | Concentration |
|---|---|
| mGAM broth base (as above) | 59.0 g |
| Agar (microbiological grade) | 15.0 g |
Use and Applications
- Universal anaerobe enrichment in Japanese R&D and pharma workflows — broth and agar formats; the de facto standard medium in Japanese anaerobic microbiology.
- JCM-deposit growth medium — Japan Collection of Microorganisms recommends mGAM for the majority of obligate-anaerobe deposits.
- Cell-bank holding and working-cell-bank propagation for Clostridium, Bacteroides, Bifidobacterium, Lactobacillus (now Lactobacillus sensu stricto plus 25 reclassified genera per Zheng et al. 2020 IJSEM 70:2782) in pharma / live biotherapeutic product manufacturing.
- Primary isolation of intestinal anaerobes from clinical and research samples (Mitsuoka's original use case).
- Anaerobic AST as an alternative to Wilkins-Chalgren in laboratories that prefer Japanese-pharmacopoeial-tradition methods (CLSI M11 reference remains WCh).
- Spore germination and outgrowth of Clostridium and related spore-formers — the dual reductant system favours rapid germination.
- Comparative-medium studies as the Japanese-reference benchmark against YCFA, BHI-S, Wilkins-Chalgren, and Modified Chopped Meat Broth.
Compatible Microorganisms
Obligate anaerobes — Mitsuoka 1965 / Nissui 05426 validated organisms
- Bacteroides fragilis (ATCC 25285 = JCM 11019), B. thetaiotaomicron, B. vulgatus, B. uniformis
- Parabacteroides distasonis, P. merdae, P. johnsonii
- Prevotella spp., Porphyromonas spp.
- Fusobacterium nucleatum, F. necrophorum, F. varium
- Clostridium perfringens (ATCC 13124 = JCM 1290), C. sporogenes, C. butyricum, C. tetani, C. novyi, C. septicum
- Clostridioides difficile (Lawson 2016 reclassification)
- Peptostreptococcus anaerobius, Finegoldia magna, Anaerococcus spp., Peptoniphilus spp.
- Cutibacterium acnes (Scholz & Kilian 2016 reclassification)
- Eggerthella lenta (formerly E. lentum)
- Veillonella parvula, V. atypica
- Lactobacillus sensu stricto and the 25 reclassified genera per Zheng et al. 2020: e.g. Lactobacillus acidophilus, Lactiplantibacillus plantarum (formerly L. plantarum), Limosilactobacillus reuteri (formerly L. reuteri), Levilactobacillus brevis (formerly L. brevis), Lacticaseibacillus rhamnosus (formerly L. rhamnosus), Lacticaseibacillus paracasei
- Bifidobacterium spp.
- Eubacterium sensu lato (note: many reclassified to Agathobacter, Anaerobutyricum, Eubacterium sensu stricto)
- Actinomyces spp.
Preparation
Critical control points
- Autoclave temperature. Mitsuoka 1965 specifies 115 °C × 15 min for the broth. This preserves growth factors in digest serum and liver extract. 121 °C × 15 min is acceptable but gives slightly reduced recovery of Faecalibacterium prausnitzii and related Firmicutes.
- Dual-reductant system. The L-cysteine plus thioglycolate combination delivers a lower equilibrium Eh than YCFA's single-cysteine system. Verify by resazurin colour: pink/red = oxidised, colourless/pale yellow = reduced. Add 1 mg/L resazurin at the user's request for visual confirmation.
- Pre-reduction time. Allow 24 h equilibration inside an AAE before inoculation of strict anaerobes. The dual-reductant system reaches steady-state Eh more slowly than a single-reductant medium.
Cautions
Storage and Expiry · Safety
- Dehydrated Mixture A: 15–30 °C in original N2-flushed sealed packaging. Shelf life 30 months from manufacture.
- Stock M (menadione), optional: 4 °C, protected from light. Stable 6 months.
- Stock H (hemin top-up), optional: 4 °C, protected from light. Stable 8 weeks.
- Prepared broth, aerobic 4 °C: 4 weeks routine; 6 weeks if not subject to repeated opening.
- Prepared agar plates, aerobic 4 °C sealed: 4 weeks.
- Prepared broth, anaerobic (vacuum-sealed + O2 absorber): 6 months for strict-anaerobe use.
Safety notes. mGAM contains bovine-derived components (beef extract, digest serum, liver extract). Handle in a Class II BSC when culturing BSL-2 pathogens. L-cysteine and thioglycolate are mild eye irritants — wear nitrile gloves and safety glasses during weighing. Hemin in alkaline NaOH is corrosive. SDS available on request.
References
- Mitsuoka T. (1965). The fecal flora in man. Zentralblatt für Bakteriologie Abt. I Orig. 195: 455.
- Nissui Pharmaceutical product information sheet, Modified GAM Broth 05426; Modified GAM Agar 05425.
- Mitsuoka T. (2014). Establishment of intestinal bacteriology. Bioscience of Microbiota, Food and Health 33(3): 99–116. doi: 10.12938/bmfh.33.99.
- Goodman AL et al. (2011). Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. PNAS 108(15): 6252–6257.
- Zheng J et al. (2020). A taxonomic note on the genus Lactobacillus: Description of 23 novel genera. IJSEM 70: 2782–2858.
- JCM (Japan Collection of Microorganisms) catalogue, RIKEN BRC. https://jcm.brc.riken.jp.
- Sasaki H et al. (2019). Comparative analyses of human gut microbiota using cultivation-based and culture-independent methods. Frontiers in Microbiology 10: 1839.
